S100A16 and osteoporosis: Cluster 4 over-expressed S100A16, which serves a variety of regulatory functions in numerous human pathophysiological processes, such as inflammation, adipogenesis, osteoporosis and tumor progression, and has also been considered to be a potential marker of cancer and a novel lipogenesis promoting factor, as well as being involved in neural differentiation [30–34].